Mrs Kimberlee Kay Borneman, CNM | |
146 W Dale St, Suite 102, Waterloo, IA 50703-1901 | |
(319) 235-5050 | |
(319) 235-5107 |
Full Name | Mrs Kimberlee Kay Borneman |
---|---|
Gender | Female |
Speciality | Certified Nurse Midwife (cnm) |
Experience | 9 Years |
Location | 146 W Dale St, Waterloo, Iowa |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588047021 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | B109170 (Iowa) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Iowa Physicians Clinic Medical Foundation | 8729992318 | 972 |
News Archive
Americans may be victims of their own success when it comes to the eradication of infectious diseases and take their disease-free lives for granted, says Jorge Parada, MD, hospital epidemiologist and medical director of the Infection Prevention and Control program at Loyola University Health System.
Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.
Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.
Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.
› Verified 8 days ago
Entity Name | Iowa Physicians Clinic Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
Americans may be victims of their own success when it comes to the eradication of infectious diseases and take their disease-free lives for granted, says Jorge Parada, MD, hospital epidemiologist and medical director of the Infection Prevention and Control program at Loyola University Health System.
Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.
Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.
Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Kimberlee Kay Borneman, CNM 5002 Willowbend Rd Ne, Cedar Rapids, IA 52411-6513 Ph: (319) 431-7867 | Mrs Kimberlee Kay Borneman, CNM 146 W Dale St, Suite 102, Waterloo, IA 50703-1901 Ph: (319) 235-5050 |
News Archive
Americans may be victims of their own success when it comes to the eradication of infectious diseases and take their disease-free lives for granted, says Jorge Parada, MD, hospital epidemiologist and medical director of the Infection Prevention and Control program at Loyola University Health System.
Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.
Scientists from A*STAR's Institute of Medical Biology (IMB) in Singapore and the University of Hong Kong's Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide. This model has allowed them to make new discoveries concerning the mechanism by which progeria works.
Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.
› Verified 8 days ago
Krista Rae Miller, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3421 W 9th St, Waterloo, IA 50702 Phone: 319-272-8000 | |
Karlea J Norby, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 146 W Dale St, Suite 102, Waterloo, IA 50703 Phone: 319-235-5050 Fax: 319-235-5107 | |
Kristi Sue Allison, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3421 W 9th St Ste G4500, Waterloo, IA 50702 Phone: 319-272-8200 Fax: 319-272-0400 | |
Jessica Elizabeth Poulsen, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3421 W 9th St Ste G4500, Waterloo, IA 50702 Phone: 319-272-8200 | |
Sarah Jessica Seuntjens, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 146 W Dale St Ste 102, Waterloo, IA 50703 Phone: 319-235-5050 | |
Kimberly A Boote, C.N.M. Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 432 King Dr, Waterloo, IA 50702 Phone: 319-234-5764 Fax: 319-234-1336 | |
Amanda Jo Schroeder, CNM, WHNP-BC Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3421 W 9th St Ste G4500, Waterloo, IA 50702 Phone: 319-272-8200 |